Streamlining the process to approve new drugs can save lives
My heart sinks each time I see the subject line in this too common email I receive in my medical practice: “Sad news: Matthew was fine when he went to bed last night but his mother found him dead in bed this morning.” Matthew (not his real name) had epilepsy with seizures that persisted despite use of currently available antiseizure medications.
We started Matthew’s evaluation when the latest antiseizure medication had been …